Alain de Weck

Q: What Schools Are Affiliated With Alain de Weck

Alain de Weck is affiliated with the following schools: University of Navarra, University of Bern, University of Zurich

Alain de Weck's AcademicInfluence.com Rankings

Alain de Weck

Biology

#6087

World Rank

#8724

Historical Rank

Immunology

#331

World Rank

#344

Historical Rank

biology Degrees

Download Badge

Biology

Alain de Weck's Degrees

Doctorate Medicine University of Zurich
PhD Immunology University of Zurich

Why Is Alain de Weck Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Alain L. de Weck, , was a Swiss immunologist and allergist. His main scientific contributions were in the area of characterization and prevention of drug allergy. He was the founding director of the Institute of Clinical Immunology at the University of Bern from 1971 to 1993 and authored or co-authored over 600 peer-reviewed publications. He is the recipient of a number of patents that led to commercial allergy products and services. He served as president of international scientific organizations such as the International Union of Immunological Societies and the International Association for Allergy and Clinical Immunology and was founder and later CEO of the Centre Médical des Grand-Places company, acquired by Heska of Fort Collins in 1997. In later years he continued his research at the University of Navarra in Spain and wrote on a wide range of topics such as the distinction between science and pseudo-science, the emergence of genetically modified organisms and comparative health care policy.

(See a Problem?)

Alain de Weck's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Nature and extent of penicillin side-reactions, with particular reference to fatalities from anaphylactic shock. (1968) (506)
Hypersensitivity to nonsteroidal anti‐inflammatory drugs (NSAIDs) – classification, diagnosis and management: review of the EAACI/ENDA # and GA2LEN/HANNA * (2011) (375)
Flow cytometric basophil activation test by detection of CD63 expression in patients with immediate‐type reactions to betalactam antibiotics (2002) (263)
Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists (1990) (208)
Interleukin 3-dependent mediator release in basophils triggered by C5a (1989) (201)
Diagnostic Tests Based on Human Basophils: More Potentials and Perspectives than Pitfalls (2008) (187)
Leukotriene production in human neutrophils primed by recombinant human granulocyte/macrophage colony-stimulating factor and stimulated with the complement component C5A and FMLP as second signals (1988) (183)
The neutrophil-activating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils (1989) (179)
Interleukin 3 and granulocyte/macrophage-colony-stimulating factor render human basophils responsive to low concentrations of complement component C3a. (1990) (159)
The flow‐cytometric determination of basophil activation induced by aspirin and other non‐steroidal anti‐inflammatory drugs (NSAIDs) is useful for in vitro diagnosis of the NSAID hypersensitivity syndrome (2004) (138)
IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. (1991) (138)
Superoxide-dependent nitroblue tetrazolium reduction and expression of cytochrome b-245 components by human tonsillar B lymphocytes and B cell lines. (1989) (131)
Use of CD63 expression as a marker of in vitro basophil activation and leukotriene determination in metamizol allergic patients (2003) (116)
Allergen‐induced basophil activation: CD63 cell expression detected by flow cytometry in patients allergic to Dermatophagoides pteronyssinus and Lolium perenne (2001) (113)
A New Combined Test with Flowcytometric Basophil Activation and Determination of Sulfidoleukotrienes Is Useful for in vitro Diagnosis of Hypersensitivity to Aspirin and other Nonsteroidal Anti-Inflammatory Drugs (2005) (94)
The superoxide generating system of B cell lines. Structural homology with the phagocytic oxidase and triggering via surface Ig. (1988) (87)
Flow cytometric basophil activation test: a review. (2002) (74)
The major histocompatibility complex of the guinea pig. I. Serologic and genetic studies. (1975) (71)
Dog allergy, a model for allergy genetics. (1997) (67)
Cellular allergen stimulation test (CAST) 2003, a review. (2004) (66)
Lymphokine regulation of activated (G1) lymphocytes. II. Glucocorticoid and anti-Tac-induced inhibition of human T lymphocyte proliferation. (1984) (64)
Factor-dependent in vitro growth of human normal bone marrow-derived basophil-like cells (1983) (63)
Oral administration of specific antigens to allergy-prone infant dogs induces IL-10 and TGF-beta expression and prevents allergy in adult life. (2003) (62)
The role of penicilloylated protein impurities, penicillin polymers and dimers in penicillin allergy. (1968) (58)
Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. (1984) (57)
Pharmacovigilance of drug allergy and hypersensitivity using the ENDA–DAHD database and the GA2LEN platform. The Galenda project (2009) (57)
Platelet-activating factor induces mediator release by human basophils primed with IL-3, granulocyte-macrophage colony-stimulating factor, or IL-5. (1991) (56)
Production and in vivo effect of antibodies against guinea pig lymphokines. (1975) (56)
Mechanisms of serotonin-induced lymphocyte proliferation inhibition. (1984) (54)
Platelet-activating factor production in human neutrophils by sequential stimulation with granulocyte-macrophage colony-stimulating factor and the chemotactic factors C5A or formyl-methionyl-leucyl-phenylalanine. (1989) (53)
T cell reactivity to penicillin: phenotypic analysis of in vitro activated cell subsets. (1986) (51)
Nonsteroidal anti-inflammatory drug hypersensitivity syndrome. A multicenter study. I. Clinical findings and in vitro diagnosis. (2009) (50)
Flow-Cytometric Cellular Allergen Stimulation Test in Latex Allergy (2003) (50)
Specific inhibition of allergic reactions to penicillin in man by a monovalent hapten. II. Clinical studies. (1972) (46)
Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines. (1976) (45)
IgE sensitivity and cross-reactivity to crude and purified mite allergens (Der f 1, Der f 2, Der p 1, Der p 2) in atopic dogs sensitive to Dermatophagoides mite allergens. (1999) (45)
CD63 expression by flow cytometry in the in vitro diagnosis of allergy to omeprazole (2003) (45)
A single-photon imaging system for the simultaneous quantitation of luminescent emissions from multiple samples. (1988) (44)
Sulfidoleukotriene generation from peripheral blood leukocytes of horses affected with insect bite dermal hypersensitivity. (1999) (44)
The reaction of benzylpenicillin with carbohydrates at neutral pH with a note on the immunogenicity of hapten polysaccharide conjugates. (1967) (42)
Effect of recombinant human interleukin 4 on spontaneous in vitro human IgE synthesis* (1988) (39)
Specific inhibition of allergic reactions to penicillin in man by a monovalent hapten. I. Experimental immunological and toxicologic studies. (1972) (37)
Dot-immunobinding assay with monoclonal anti-IgE antibodies for the detection and quantitation of human IgE. (1986) (35)
Bird-egg syndrome. Cross-reactivity between bird antigens and egg-yolk livetins in IgE-mediated hypersensitivity. (1988) (34)
Hypersensitivity to aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs). (2006) (34)
Genetic control of sensitization to structurally unrelated antigens and its relationship to histocompatibility antigens in guinea-pigs. (1975) (34)
History and classification of anaphylaxis. (2010) (34)
Anti-amiodarone antibodies: detection and relationship to the development of side effects. (1988) (33)
Anti-IgE autoantibodies mistaken for specific IgG. (1992) (33)
Assessment of interleukin 1 and interleukin 2 effects on cycling and noncycling murine thymocytes. (1982) (33)
Equine leukocyte antigen system. II. Serological and mixed lymphocyte reactivity studies in families. (1980) (32)
Basophil histamine release and leukotriene production in response to anti-IgE and anti-IgE receptor antibodies. Comparison of normal subjects and patients with urticaria, atopic dermatitis or bronchial asthma. (1996) (31)
Suppression of the benzylpenicilloyl- (BPO) specific IgE formation with isologous anti-idiotypic antibodies in BALB/c mice. (1980) (31)
Antibodies to guinea pig lymphokines. IV. Suppression of the mixed leukocyte culture reaction by anti-lymphokine globulin. (1976) (31)
Cellular tests in the diagnosis of drug hypersensitivity. (2008) (31)
Equine leukocyte antigen system. I. Serological studies. (1980) (30)
Nonsteroidal anti-inflammatory drug hypersensitivity syndrome: a multicenter study. II. Basophil activation by nonsteroidal anti-inflammatory drugs and its impact on pathogenesis. (2010) (30)
Regulation of the IgE antibody response by idiotype-anti-idiotype network. (1982) (29)
Cell-mediated and humoral immune response in swine after vaccination and natural infection with Mycoplasma hyopneumoniae. (1981) (29)
Importance of Early Allergen Contact for the Development of a Sustained Immunoglobulin E Response in a Dog Model (2003) (28)
Interleukin 8-inhibitor and inducer of histamine and leukotriene release in human basophils. (1991) (27)
Studies on the direct neutral penicilloylation of functional groups occurring on proteins. (1968) (26)
Age-related changes of mitogen responsiveness in different lymphoid organs from outbred NMRI mice. (1981) (26)
Thymocyte activation by cytokines: direct assessment of G0-G1 transition by flow-cytometry. (1980) (26)
Histocompatibility antigens and genetic control of the immune response in guinea pigs. III. Specific inhibition of antigen-induced lymphocyte proliferation by strain-specific anti-idiotypic antibodies (1976) (25)
[Cheese washer's disease ("Kaesewascherkrankheit"), a special form of farmer's lung syndrome]. (1969) (25)
Suppression of reaginic antibody formation in guinea pigs by anti-idiotypic antibodies. (1978) (25)
IgE-reactivity to major Japanese cedar (Cryptomeria japonica) pollen allergens (Cry j 1 and Cry j 2) by ELISA in dogs with atopic dermatitis. (2000) (24)
In vitro stimulation of bovine leucocytes by phytohaemagglutinin and other mitogens. (1974) (24)
Regulation of mediator release by human basophils: importance of the sequence and time of addition in the combined action of different agonists. (1991) (24)
Immunological effects of aspirin anhydride, a contaminant of commercial acetylsalicylic acid preparations. (1971) (23)
Human IgE mRNA expression by peripheral blood lymphocytes stimulated with interleukin 4 and pokeweed mitogen (1990) (23)
Immunological Tolerance Induced in Animals Previously Sensitized to Simple Chemical Compounds (1964) (22)
Leucocyte typing in guinea pigs. (1972) (22)
IgG anti-IgE autoantibodies in immunoregulation. (1991) (21)
Studies on the mechanism of platelet-activating factor production in GM-CSF primed neutrophils: involvement of protein synthesis and phospholipase A2 activation. (1990) (21)
A dual microtiter plate (192 sample) luminometer employing computer-aided single-photon imaging applicable to cellular luminescence and luminescence immunoassay. (1989) (21)
RECENT CLINICAL AND IMMUNOLOGICAL ASPECTS OF PENICILLIN ALLERGY. (1965) (21)
Human lymphocyte proliferation II. Formation of activated (G1) cells (1982) (21)
IMMUNOLOGICAL UNRESPONSIVENESS IN ALLERGIC CONTACT DEMATITIS TO DINITROCHLOROBENZENE IN GUINEA PIGS. (1964) (21)
Immunochemical aspects of penicillin chemistry. (1969) (20)
THE IMMUNOGENICITY OF DINITROPHENYL AMINO ACIDS (1969) (20)
Determination of histocompatibility antigens by leukocyte typing in outbred guinea pigs and effect of matching on skin graft survival. (1971) (19)
Aging and immunity: decrease in interleukin-2 production and interleukin-2-dependent RNA-synthesis in lectin-stimulated and murine spleen cells. (1982) (19)
Lymphokines. I. Use of insoluble concanavalin A for the production of migration inhibitory factor in guinea pig lymphocyte cultures. (1975) (18)
Lymphokine regulation of human lymphocyte proliferation: formation of resting G0 cells by removal of interleukin 2 in cultures of proliferating T lymphocytes. (1984) (18)
For allergy diagnostic flow cytometry, detection of CD203c instead of CD63 is not at all an improvement in other hands. (2003) (18)
Immune and non-immune responses to monovalent low molecular weight penicilloyl-polylysines and penicilloyl-bacitracin in rabbits and guinea-pigs. (1968) (17)
The effect of terfenadine on the immediate and late-phase reactions mediated by immunoglobulin E. (1993) (17)
Correspondence: Flow cytometry and basophil activation test (2003) (16)
Distinction of the human basophil promoting activity from human interleukin-3. (1985) (16)
Antigen specific quantification of sulfidoleukotrienes in patients allergic to Betalactam antibiotics. (2005) (16)
Canine lymphocyte cultures in vitro: evaluation of peripheral blood lymphocyte response to mitogens. (1982) (16)
Simplified sulfidoleukotriene ELISA using LTD4-conjugated phosphatase for the study of allergen-induced leukotriene generation by isolated mononuclear cells and diluted whole blood. (1994) (15)
Differences of T-cell activation by the anti-CD3 antibodies Leu4 and BMA030. (1987) (15)
A new chemical spect of penicillin allergy: the direct reaction of penicillin with epsilon-amino-groups. (1965) (15)
Analysis of 3H-histamine interaction with lymphocytes: receptor binding or uptake? (1983) (15)
Monovalent elicitation of passive cutaneous anaphylaxis by N1-DNCP-N6-BPO-diaminohexane. (1979) (14)
Proceedings: Stimulation of penicillin-sensitive lymphocytes by antigenic determinants covalently bound to cell membranes. (1974) (14)
[New perspectives in the modulation of allergic inflammation]. (1990) (14)
Evaluation of intrinsic and extrinsic penicilloyl-specific immunogenicity of penicillins. The use of penicillin hydrolysis catalyzed by 3,6-bis-(dimethylaminomethyl) catechol. (1970) (13)
Human lymphocyte proliferation. I. Correlation between activated and proliferating T-lymphocytes. (1982) (13)
Histocompatibility antigens and genetic control of the immune response in guinea pigs. I. Specific inhibition of antigen‐induced lymphocyte stimulation by alloantisera (1974) (13)
The swine histocompatibility system SLA: serological studies in the common Swiss and Danish swine breeds. (2009) (13)
Interleukin 1- and 2-like activities in the dog. (1984) (13)
Receptor-operated activation of polymorphonuclear leukocytes: different effects of NAP-1/IL-8 and fMet-Leu-Phe or C5a. (1991) (13)
Schistosome-derived inhibitory factor: an immunosuppressive agent preferentially active on T lymphocytes. (1986) (13)
Characterization of two dog IgE-specific antibodies elicited by different recombinant fragments of the epsilon chain in hens. (1998) (13)
Clinical trial of Ro 6-0787, a monovalent specific hapten inhibitor of penicillin allergy. (1975) (13)
Selective stimulation of CD4+ versus CD8+ T-cell subsets in symptomatic and asymptomatic HIV-1-infected individuals. (1991) (13)
The effect of Leishmania tropica on stimulation of lymphocytes with phytohaemagglutinin. (1976) (13)
Different effects of IL-2 addition or antibody crosslinking on T-cell subset stimulation by CD3 antibodies. (1986) (13)
Linkage of guinea pig Bf and C4 TO THE GPLA. (1977) (12)
Histamine release from human leukocytes by anti-IgE antibodies: influence of multiple or single epitope recognition. (1986) (12)
Allergic pulmonary and ocular tissue responses in the absence of serum IgE antibodies (IgE) in an allergic dog model. (2002) (12)
The induction of contact hypersensitivity to dinitrochlorobenzene (DNCB) in guinea-pigs by dinitrophenyl-amino acids. (1966) (12)
Drug allergy, immunotherapy, immune complexes and anaphylaxis. (1989) (11)
GUINEA PIG HISTOCOMPATIBILITY ANTIGENS I. SEROLOGICAL AND GENETIC CHARACTERIZATION OF GPLA ANTIGENS (1976) (11)
Potential role of anti-IgE antibodies in vivo. (1989) (11)
Effect of schistosome-derived inhibitory factor on the cell cycle of T lymphocytes. (1987) (11)
Solubility enhancing haptens: preparation and some properties of conjugates with dinitrocarboxyphenyl (DNCP) groups. (1974) (11)
[Urticarial skin reaction to codeine, a measure of mast cell reactivity]. (1980) (11)
Drug hypersensitivities: which room for biological tests? (2005) (11)
Characterization of a human basophil-like cell promoting activity. (1988) (11)
[Sensitization to phenacetin: immunological aspects]. (1973) (11)
Suppression of anti-hapten IgE and IgG antibody responses by isologous anti-idiotypic antibodies against purified anti-carrier (ovalbumin) antibodies in BALB/c mice. (1981) (10)
Lymphokine production by human peripheral blood lymphocytes: analysis by in situ hybridization. (1988) (10)
Ageing and immunity in outbred NMRI mice: lack of correlation between age-related decline of the response to T cell mitogens, the antibody response to a T-dependent antigen and lifespan in outbred NMRI mice. (1981) (10)
Factors influencing human IgE synthesis in vitro and in vivo. (1985) (10)
Influence of IgE fragments on IgE determination. (1990) (10)
Molecular basis of T cell dependent genetic control of the immune response in the guinea pig. (1977) (10)
HLA and allergy. (1977) (10)
Critical evaluation of the use of skin tests and cellular tests in standardization of allergens. (1994) (9)
Cell cycle-related changes in number of T-lymphocyte receptors for glucocorticoids and insulin. (1984) (9)
Diagnostic reagents in drug allergy: immunochemical specificity in the 1,2-diphenyl-pyrazolidinedione series. (1986) (9)
Aspects of formation of the D-penicillamine-antigenic determinant from penicilloyl compounds. (1973) (9)
Evaluation of genetic control of the immune response to penicillin in man. (1977) (9)
[Pituitary snuff taker's lung]. (1970) (9)
Age-related changes in the formation of glucocorticoid and insulin receptors during lectin-induced activation of human peripheral blood lymphocytes. (1985) (9)
Studies on penicillin hypersensitivity. I. The specificity of rabbit "anti-penicillin" antibodies. (1962) (9)
Studies on the induction of immunological tolerance by antigen in guinea-pigs already sensitized to dinitrochlorobenzene. (1971) (9)
Further biochemical characterization of human basophil-like cell-promoting activity and its distinction from human interleukin-3-like activity. (1988) (9)
The Carl Prausnitz Memorial Lecture. What can we learn from the allergic zoo? (1995) (9)
Investigation of a syngeneic murine model for the study of IgE antibody regulation with isologous antiidiotypic antibodies. (1981) (9)
Antibodies to guinea-pig lymphokines. V. Suppression of normal lymphocyte transfer, immune lymphocyte transfer and direct reactions in the guinea-pig by anti-lymphokine globulin. (1977) (9)
Domain mapping and comparative binding features of eight dog IgE-specific reagents in ELISA, immunoblots, and immunohistochemistry. (1999) (8)
[Hemolytic autoimmune anemia caused by (+)-cyanidanol-3 (Catergen)]. (1980) (8)
Allergic and immunological aspects of therapy with cefotaxime and other cephalosporins. (1980) (8)
[Allergic alveolitis as a result of mold on the bedroom wall]. (1981) (8)
Induction of granulocyte chemiluminescence by a mediator derived from human monocytes. (1986) (8)
["Cheesewasher's disease". Immunologic and epidemiologic study]. (1972) (8)
Characteristics of the in vitro stimulation of horse leucocytes by phytohemagglutinin and antigen. (1973) (7)
Peptide analogues of consensus receptor sequence inhibit the action of cytokines on human basophils. (1992) (7)
Effect of cyclosporin A on the early activation of human T helper lymphocytes: inhibition of RNA-synthesis and modification of the expression of activation antigens. (1985) (7)
Immunochemical particularities of anaphylactic reactions to compounds used in anesthesia. (1993) (7)
Pharmacological and immunological aspects of histamine release from horse leucocytes. (1980) (7)
Biological and biochemical characteristics of the basophil-like cell promoting activity (BaPA) and a human IL 3-like activity. (1986) (7)
Interference of a C3-fragment preparation with IL 2-dependent proliferation. (1986) (7)
Some observations on the molecular mechanisms of immediate-type allergic reactions. (1969) (7)
Active and passive cutaneous anaphylaxis in the horse following immunization with benzylpenicilloyl-bovine gamma globulin (BPO20-BGG). (1973) (7)
Biochemical characterization of the human basophil-promoting activity. (1987) (7)
The role of amino-reactive impurities in acetylsalicylic acid allergy. (1975) (6)
Induction of immunological tolerance to the penicilloyl antigenic determinant. III. Suppression of benzylpenicilloyl-specific IgE antibody formation by cleavable penicilloylated dextran. (1981) (6)
SOME IMMUNOCHEMICAL PROPERTIES OF PENICILLENIC ACID (1960) (6)
Incorporation of biotinylated nucleotides for the quantification of PCR-amplified HIV-1 DNA by chemiluminescence. (1991) (6)
Use of Flow Cytometry to Assess Basophil Activation in Patients Allergic to Betalactam Antibiotics: Correlation between Flow-Cytometric Allergen Stimulation Test and Other in vivo and in vitro Tests (2001) (6)
Determination of rat mast cells by flow-cytometry. (1980) (6)
Lymphokines. II. Use of horse monocytes as indicator cells for human MIF. (1976) (6)
Pathophysiologic mechanisms of allergic and pseudo-allergic reactions to foods, food additives and drugs. (1984) (6)
[Analysis of T-cell subpopulations. Pathophysiological concept and significance for clinical medicine]. (1985) (6)
[Histamine release from equine leucocytes provoked by fungal allergens]. (1982) (6)
A revised nomenclature for allergy--reflexions of an old-timer. (2002) (6)
Lymphocyte transformation by insulin and insulin-zinc suspensions. (1982) (6)
Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. I. Sensitization to NEO. Overall results and experiments on the skin testing technique. (1966) (5)
Age-related changes in g0-g1 transition and proliferative capacity of mitogen-stimulated murine spleen cells. (1982) (5)
Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. IV. Desensitization to NEO. (1966) (5)
Immunologic specificity of the localized Shwartzman phenomenon induced in guinea pigs by simple chemical haptens. (1968) (5)
[Nature and extent of penicillin side effects with special reference to 151 fatal cases after anaphylactic shock]. (1969) (5)
Immunogenicity of fully defined lysine LAG dodecapeptides in guinea-pigs: with a note on an antigenic cooperation effect in the delayed immune response. (1972) (5)
Studies on penicillin hypersensitivity. II. The role of the side chain in penicillin antigenicity. (1962) (5)
Technical aspects of low 3H-thymidine incorporation by mitogen stimulated canine peripheral blood lymphocytes in vitro. (1982) (5)
Failure of covalently cross-linked human IgG myeloma subclass protein to release histamine from human leukocytes. (1984) (5)
[New pathophysiological concepts on aspirin hypersensitivity (Widal syndrome); diagnostic and therapeutic consequences]. (2005) (5)
Differential expression of cytokine mRNAs in human cell lines. (1989) (5)
Flow-cytometric analysis of human basophil degranulation. III. Degranulation induced by allergens and antibodies in hay fever and bee venom allergic patients. (1981) (5)
Immunological tolerance in contact-hypersensitivity to dinitrochlorobenzene. Dose and time dependence. Possible cellular kinetics. (1971) (5)
Atopic and Nonatopic IgE-Mediated Allergy: A New Interpretation of Old Facts? (2002) (4)
Control of immune complex and zymosan-mediated anaphylatoxin generation by proteins B and H of the alternative complement pathway. (1984) (4)
Report on the joint I. U. I. S.-W. H. O. workshop, "standardization of allergens" held at the Royal Danish School of Pharmacy, Copenhagen, on July 1974. (1975) (4)
Suppression of established IgE antibody responses with isologous anti-idiotypic antibodies in guinea pigs. (1986) (4)
Molecular models for induction of the immune response and their relationship to the genetic control of histocompatibility antigens. (1972) (4)
[Demonstration of drug-specific IgE and IgG antibodies using RIA: clinical importance as shown with nomifensin (Alival)]. (1983) (4)
Activity and molecular properties of mitogenic factors produced by mixed lymphocyte reactions (MLC-MF) in humans and guinea pigs. (1979) (4)
The introduction of one or two 3β‐cholestanyl residues into benzylpenicilloyl‐eicosa‐L‐lysines greatly potentiates their tolerogenicity for anti‐benzylpenicillol IgE antibody formation (1984) (4)
Diagnostic approaches to allergy. (1993) (4)
Relation of supernatant IL-2 to steady state levels of IL-2 mRNA. (1986) (4)
Evaluation of murine thymocyte stimulation using a defined culture medium. (1982) (4)
Cytokine gene expression in atopics: effect of IL-4 on IL-1 beta and IL-6 mRNA levels. (1990) (4)
Proceedings: Genetic control of sensitization to chemically defined antigens and its relationship to histocompatibility antigens in guinea pigs. (1974) (4)
Effect of passively administered isologous anti-idiotypes directed against anti-carrier (ovalbumin) antibodies on the anti-hapten IgE and IgG antibody responses in BALB/c mice. (1983) (4)
Factors influencing proliferation and histamine content of cultured human bone marrow cells. (1989) (4)
HL-A typing and cadaver-kidney transplants. (1971) (4)
[Impressive course in a case of budgerigar breeder's disease]. (1972) (3)
[Nature and scope of adverse effects of penicillin with special reference to 151 deaths following anaphylactic shock]. (1969) (3)
Are allergen-specific IgG mainly IgG anti-IgE autoantibodies? (1991) (3)
[A new skin test for the detection of penicillin allergy]. (1963) (3)
Transcription and translation dependent induction of interleukin 2 (IL-2) and IL-2 receptors. (1984) (3)
Characterization of T8 epitopes by enzymatic digestion, crossblocking, and involvement in cell-mediated lympholysis. (1985) (3)
Different T cell subset stimulation by IgG1 or IgG2a anti-T3 antibodies. (1986) (3)
Allergy mediator assays: a new dimension in allergy diagnosis. (1995) (3)
Chemiluminescence of mononuclear cells is enhanced during antigen recognition. (1993) (3)
In vitro IgE but not IgG production of canine peripheral blood B cells is inhibited by CD40 ligation. (2000) (3)
Human T hybridoma-derived immunoglobulin-binding factors. (1987) (3)
Antigenicity and nutritional value of selected milk proteins and their hydrolysate in growing rats. (1996) (3)
The multiple role of cytokines in IgE-mediated allergic reactions. (1992) (3)
Immunogenicity of p-phenetidine, 2-hydroxy-p-phenetidine and their protein conjugates in guinea pigs, rabbits and man. (1977) (3)
The induction of immunological tolerance during the primary response. (1972) (3)
Penicillin Allergy: Its Detection by an Improved Hæmagglutination Technique (1964) (3)
Guinea pig histocompatibility antigens. III. Analysis of normal lymphocyte transfer (NLT) reactions among guinea pigs with serologically defined phenotypes (GPL-AB locus and I region). (1976) (3)
Newer developments in penicillin immunochemistry. (1963) (2)
New perspectives in the modulation of allergic inflammation. (1989) (2)
Immunosuppression by antigen? (1969) (2)
Cytokines in allergic inflammation. (1993) (2)
[Allergies, an increasing public health problem: causes and consequences]. (2000) (2)
Long-lasting polymorphonuclear leukocyte oxidative burst activation by products of lipopolysaccharide-treated mononuclear cells is only partially due to tumor necrosis factor. (1990) (2)
Haplotype designations of various strains of guinea pigs. (1978) (2)
[The CEA test and other immunological tests as disease course controls in gastrointestinal adenocarcinoma]. (1977) (2)
[Clinical immunological tests]. (1973) (2)
[Radioimmunologic detection of IgE and IgG antibodies against drugs. Conclusions after experience with over 1200 patients]. (1986) (2)
Rat mast cell degranulation triggered by murine anti-idiotypic antibodies. (1980) (2)
[Relationship between T-subsets and clinical aspects of HIV-associated diseases]. (1991) (2)
Induction of immunological tolerance to the penicilloyl antigenic determinant--IV. The effect of BPO-oligolysines and cholestanol-bearing BPO-oligolysines on murine IgE responses. (1983) (2)
Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. II. Influence of various factors on sensitization to NEO. (1966) (2)
[Chemical aspects of penicillin allergy. The direct penicilloylation of epsilon-amino groups by penicillin at pH 7.4]. (1966) (2)
Effect of epitope density on the induction of the IgE immune response in mice. (1980) (2)
Antibodies to Guinea Pig Lymphokines (1976) (2)
[What is an antigen?]. (1967) (2)
[Nature and extent of penicillin side effects with special consideration of 151 fatalities following anaphylactic shock]. (1969) (2)
Production and characterization of antisera against human macrophage migration inhibitory factor (MIF). (1980) (2)
[Longitudinal studies on cellular immunity in patients with neoplasms]. (1972) (2)
Allergen standardization at a crossroads? (1997) (2)
Food allergy: problems, fiction and hard facts. (1996) (2)
Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages. (1978) (1)
Immune responses to environmental antigens that act on the skin: the role of lymphokines in contact dermatitis. (1977) (1)
[Variations of the sebaceous skin layer of the forearm according to age and sex]. (1955) (1)
Sensitization, immunological tolerance and desensitization of guinea pigs to neoarsphenamine. 3. Immunological tolerance to NEO. (1966) (1)
Analysis of lymphocyte proliferation by cytofluorometric techniques in aging and various clinical conditions. (1984) (1)
[Allergology general practice in Switzerland: present and future]. (1994) (1)
Enhancement of mononuclear cell oxidative burst by early post-transfer sera from human patients after unsuccessful embryo transfer. (1990) (1)
["Cheesewasher disease". Immunologic and epidemiologic studies]. (1972) (1)
Radiosensitive suppressor T cells for LIF production in mixed lymphocyte reactions. (1984) (1)
[Effect of anti-idiotypes on the production of phosphorylcholine-specific antibodies]. (1981) (1)
[Studies of penicillin allergy. IV. Skin tests in penicillin allergy]. (1962) (1)
[The clinical significance of anti-IgE antibodies in the treatment of allergic rhinopathy]. (1990) (1)
[On pseudomonovalent penicilloyl carbohydrates (author's transl)]. (1973) (1)
A RAST assay for monitoring specific IgE antibodies in the mouse. (1981) (1)
A novel interleukin stimulating free radical production by granulocytes. (1987) (1)
Flow-cytofluorometric determination of active and total rosettes. (1980) (1)
[Sensitization studies using dexamethasone and carboxymethylcellulose in the horse]. (1972) (1)
A 3β‐cholestanyl‐containing mono‐benzylpenicilloyl oligoamide and peptide suppress anti‐benzylpenicilloyl antibody formation in mice (1985) (1)
The formation of penicillin antigens. (1968) (1)
[Differentation of penicilloic acids from functional derivatives of their alpha carboxyl group with the penamaldate stability test]. (1966) (1)
The immunogenicity of phenacetin and some of its metabolites in guinea pigs. (1974) (1)
[Experimental eczema. II. Guinea pig sensitization with dinitrochlorobenzene and picryl chloride]. (1956) (0)
Summing up: soluble mediators of immunity. (1979) (0)
Current perspectives on the diagnosis of drug allergy. (1988) (0)
Memories: Failures and Dreams by Alain de Weck. A Book Review: Erratum (2009) (0)
[Current concepts in the regulation of the immunologic response]. (1989) (0)
Lymphokines, monokines and cytokines: an increasingly valuable object for studies in molecular immunology. (1980) (0)
[Lymphokines, monokines, and cytokines: mediators of intercellular messages]. (1982) (0)
[How atoxic are penicillins?]. (1983) (0)
Immunochemical mechanisms involved in antibiotic hypersensitivity. (1970) (0)
[Penicillin allergy]. (1970) (0)
[Acetylsalicylic acid: an old drug from a current viewpoint]. (1971) (0)
[Chicken breeder's lung]. (1969) (0)
[Studies on allergy to pencillin. III. New immunochemical aspects]. (1962) (0)
[New immunologic perspectives on specific desensitization]. (1977) (0)
[Comparative study on the immunogenicity of plasma substitutes with gelatin base in animal experiments]. (1978) (0)
Lymphocyte active serum factors. (1974) (0)
Determination by Flow Cytometry of Activated Basophils in Patients Sensitized to Dermatophagoides pteronyssinus and Lolium perenne (2001) (0)
History and future of allergen standardization and of the Paul-Ehrlich-Seminar. (2003) (0)
[Cellular and molecular mechanisms of immunopathologic lesions]. (1969) (0)
[Perspectives of immunopharmacology]. (1985) (0)
[Interstitial pulmonary diseases caused by IgG type of immunoglobulins. Some immunological and epidemiological aspects in Switzerland]. (1971) (0)
[What is the future of allergology?]. (1986) (0)
[Immediate hypersensitivity reactions: interactions between mediators and cells]. (1980) (0)
A cooperative kidney typing and exchange program. (1970) (0)
[Questions from clinical practice. (Recurrent urticaria)]. (1976) (0)
Pharmacologic and Immunochemical Mechanisms of Drug Hypersensitivity (1991) (0)
[Experimental eczema. III. The protective effect of acanthosis]. (1957) (0)
[Technic of leukocyte typing (present condition)]. (1970) (0)
[Cutaneous reticuloendothellosis in Whipple's disease]. (1957) (0)
[The immunochemistry of penicillin allergy]. (1962) (0)
[Transplantation immunology]. (1972) (0)
Clinical aspects of immunology, 4th edn (2 vols) edited by P. J. Lachmann and D. K. Peters, Blackwell Scientific Publications, 1982. £90 (xvi + 1004 pages) ISBN 0 632 00702 8. (1982) (0)
[Antigenicity of hapten-polysaccharide conjugates]. (1971) (0)
[Accumulation of eosinophils in the nasal secretion in patients with bronchial asthma]. (1981) (0)
[Inhibition of allergic reactions to penicillin by penicilloyl-alpha-amide and chemically related substances]. (1969) (0)
[Diagnosis of drug-induced allergies]. (1965) (0)
[Clinico-immunologic tests--state-of-the-art 1983]. (1984) (0)
Alain de Weck (1928-2013). Fribourg, Switzerland. (2014) (0)
Genetic control of the immune response to drugs and synthetic antigens. (1970) (0)
Measurement of antilymphokine serum activities by the electrophoretic mobility test. (1982) (0)
[Comments on the paper: "3 incidents following intradermal tests with penicilloyl-polylysin" by I. Lückerath and G.K. Steigleder (Hautarzt 18, 183-5, 1967)]. (1967) (0)
Perspectives in Allergy Diagnosis. (1992) (0)
[Diagnosis of penicillin-induced lethal anaphylactic shock, Diagnosis on a cadaver]. (1973) (0)
[Chemical aspects of penicillin allergy. The direct formation of penicilloyl determinants in penicillin]. (1966) (0)
[Penicillin allergy]. (1966) (0)
History of the World Allergy Organization: The First 50 Years of IAA/IAACI/WAO (2011) (0)
[Intrauterine sensitization against drugs?]. (1973) (0)
Flow-cytometric analysis of mouse pritoneal macrophages. (1980) (0)
Immunological and non-immunological mechanisms of intolerance reactions to aspirin. (1974) (0)
Conventional and new approaches to hyposensitization. (1989) (0)
[New aspects of drug hypersensitivity]. (1972) (0)
[The experimental eczema in guinea pigs]. (1957) (0)
Induction of tolerance during the primary response to simple chemicals. (1971) (0)
[SENSITIZATION, INHIBITION AND IMMUNOLOGICAL TOLERANCE TO SIMPLE CHEMICAL BODIES IN GUINEA PIGS]. (1964) (0)
Drug Allergy [Abridged] (1968) (0)
Trends and opportunities in allergy research in Europe. (1991) (0)
[Not Available]. (1956) (0)
Molecular mechanism of T and B lymphocyte triggering. (1975) (0)
[Clinical-immunological tests; current state]. (1977) (0)
[Immunological activity of residues from penicillin fermentation media and their significance for penicillin allergies]. (1970) (0)
THE ROYAL CANADIAN DENTAL CORPS FIFTIETH ANNIVERSARY: 1915-1965. (1965) (0)
Farewell address. 40 years allergo-immunology: from the nipple unto milk. (1994) (0)
Production of IgE-binding factor by human buffy coat cells. (1983) (0)
Peptide antigens for the study of interactions between determinants, antibodies and immunologically active cells. (1973) (0)
[Immunosuppression (theoretical basis)]. (1972) (0)
Drugs as allergens. (1986) (0)
[Immunological mechanisms of allergy reactions to antibiotics: topical aspects of penicillin therapy (author's transl)]. (1973) (0)
[On the relationship between dermatomycoses and penicillin hypersensitivity]. (1966) (0)
[Letter: Diagnosis of farmer's lung]. (1976) (0)
Allergic reactions to penicillins. Advances in understanding and management. (1969) (0)
Does the clinical experience with non-sedating H1-antagonists justify a reassessment of antihistamines in allergy treatment? (1990) (0)
Evaluation of the new Cobas Core IgE Total EIA in comparison to three commercial IgE immunoassays. (1994) (0)
[Use of bacteriophage inhibition technic for the determination of antibodies against chemically defined antigens]. (1972) (0)
An explanation of the mode of action of Gynatren/SolcoTrichovac based on immunological considerations. (1984) (0)
[Hematologic aspects of delayed hypersensitivity]. (1967) (0)
[Interstitial pneumopathies caused by inhaled antigens (farmer's lung): a new form of allergic lung disease]. (1970) (0)

This paper list is powered by the following services:

Other Resources About Alain de Weck

en.wikipedia.org

What Schools Are Affiliated With Alain de Weck?

Alain de Weck is affiliated with the following schools:

Alain de Weck's Academic­Influence.com Rankings